Association between resistance-associated NS5A variants of hepatitis C virus and efficacy of direct-acting antivirals in human hepatocyte transplanted mice 1) Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice 2) Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure

k7998_1

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

k7998_1.pdf

https://hiroshima.repo.nii.ac.jp/record/2003149/files/k7998_1.pdf

ファイル	ライセンス
k7998_1.pdf (481.1 kB) sha256 38206ae440dd96fb25b4117a90651831f92856fab45afd1a10cfe448450d5881

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays